Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.350
+0.010 (0.75%)
At close: Apr 28, 2026, 4:00 PM EDT
1.390
+0.040 (2.96%)
Pre-market: Apr 29, 2026, 8:45 AM EDT
Dogwood Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -34.26 | -12.35 | -5.3 | -12.25 | -15.96 | |
| Depreciation & Amortization | 0.07 | 0.01 | - | - | - | |
| Other Amortization | 0.05 | 0.06 | - | - | - | |
| Loss (Gain) From Sale of Assets | 0 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | 11.91 | - | - | - | - | |
| Stock-Based Compensation | 0.36 | 0.48 | 0.62 | 0.58 | 0.32 | |
| Other Operating Activities | 6.38 | 3.59 | - | - | - | |
| Change in Accounts Payable | -0.53 | 0.22 | -0.46 | 0.22 | 0.27 | |
| Change in Other Net Operating Assets | 0.4 | -0.8 | 0.27 | -0.02 | -0.32 | |
| Operating Cash Flow | -15.62 | -8.79 | -4.87 | -11.47 | -15.69 | |
| Cash Acquisitions | - | 3.76 | - | - | - | |
| Investing Cash Flow | - | 3.76 | - | - | - | |
| Long-Term Debt Issued | 3 | 15.32 | - | - | - | |
| Net Debt Issued (Repaid) | 3 | 15.32 | - | - | - | |
| Issuance of Common Stock | 4.34 | 1.38 | 1.16 | 4.49 | 0.2 | |
| Repurchase of Common Stock | - | -0 | - | - | - | |
| Other Financing Activities | -0.05 | - | - | - | -0.3 | |
| Financing Cash Flow | 7.28 | 16.7 | 1.16 | 4.49 | -0.1 | |
| Foreign Exchange Rate Adjustments | 0.01 | -0.14 | - | - | - | |
| Net Cash Flow | -8.32 | 11.53 | -3.71 | -6.98 | -15.79 | |
| Levered Free Cash Flow | -17.34 | -5.23 | -2.98 | -6.92 | -9.8 | |
| Unlevered Free Cash Flow | -17.39 | -5.23 | -2.98 | -6.92 | -9.8 | |
| Change in Working Capital | -0.13 | -0.58 | -0.19 | 0.2 | -0.05 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.